PremiumCompany AnnouncementsSumitomo Pharma Announces Reversal of Doubtful Accounts Allowance Sumitomo Pharma Boosts Financial Forecasts and Records Gains from Equity Transfers Sumitomo Pharma Extends Executive Pay Cuts Amid Financial Challenges PremiumCompany AnnouncementsSumitomo Dainippon Pharma Reports Robust Earnings Growth Sumitomo Pharma Revises Financial Forecasts, Projects Positive Turnaround Sumitomo Pharma Reports Significant Foreign Exchange Gains PremiumCompany AnnouncementsSumitomo Pharma Streamlines Workforce with Retirement Program Sumitomo Pharma Reports Significant Forex Losses Sumitomo Pharma upgraded to Neutral from Sell at Citi